139 related articles for article (PubMed ID: 38511127)
1. Ruxolitinib, IV Immunoglobulin, and High-Dose Glucocorticoids for Critically Ill Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-Center Observational Pilot Study.
Scholz L; Posch F; Schulz E; Gornicec M; Wölfler A; Reisinger AC; Reinisch A; Eller P; Eisner F; Kreuzer P; Stradner M; Rosenkranz AR; Krammer F; Schilcher G; Krause R; Hatzl S
Crit Care Explor; 2024 Feb; 6(2):e1046. PubMed ID: 38511127
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis.
Wohlfarth P; Agis H; Gualdoni GA; Weber J; Staudinger T; Schellongowski P; Robak O
J Intensive Care Med; 2019 Sep; 34(9):723-731. PubMed ID: 28631531
[TBL] [Abstract][Full Text] [Related]
3. Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.
Ahmed A; Merrill SA; Alsawah F; Bockenstedt P; Campagnaro E; Devata S; Gitlin SD; Kaminski M; Cusick A; Phillips T; Sood S; Talpaz M; Quiery A; Boonstra PS; Wilcox RA
Lancet Haematol; 2019 Dec; 6(12):e630-e637. PubMed ID: 31537486
[TBL] [Abstract][Full Text] [Related]
4. Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: A case series.
Hansen S; Alduaij W; Biggs CM; Belga S; Luecke K; Merkeley H; Chen LYC
Eur J Haematol; 2021 May; 106(5):654-661. PubMed ID: 33523540
[TBL] [Abstract][Full Text] [Related]
5. Dose-escalating ruxolitinib for refractory hemophagocytic lymphohistiocytosis.
Song Y; Li X; He X; Zhou F; Du F; Wang Z; Chen S; Wu D
Front Immunol; 2023; 14():1211655. PubMed ID: 37457729
[TBL] [Abstract][Full Text] [Related]
6. Ruxolitinib treatment permits lower cumulative glucocorticoid dosing in children with secondary hemophagocytic lymphohistiocytosis.
Chi Y; Liu R; Zhou ZX; Shi XD; Ding YC; Li JG
Pediatr Rheumatol Online J; 2021 Apr; 19(1):49. PubMed ID: 33794928
[TBL] [Abstract][Full Text] [Related]
7. Ruxolitinib is an alternative to etoposide for patient with hemophagocytic lymphohistiocytosis complicated by acute renal injury: A case report.
Yan WL; Yang SL; Zhao FY; Xu XJ
J Oncol Pharm Pract; 2022 Jan; 28(1):222-227. PubMed ID: 34074166
[TBL] [Abstract][Full Text] [Related]
8. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
[TBL] [Abstract][Full Text] [Related]
9. Short-term effectiveness of ruxolitinib in the treatment of recurrent or refractory hemophagocytic lymphohistiocytosis in children.
Wei A; Ma H; Li Z; Zhang L; Zhang Q; Wang D; Lian H; Zhang R; Wang T
Int J Hematol; 2020 Oct; 112(4):568-576. PubMed ID: 32666469
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of ruxolitinib as a front-line therapy for 12 children with secondary hemophagocytic lymphohistiocytosis.
Zhang Q; Wei A; Ma HH; Zhang L; Lian HY; Wang D; Zhao YZ; Cui L; Li WJ; Yang Y; Wang TY; Li ZG; Zhang R
Haematologica; 2021 Jul; 106(7):1892-1901. PubMed ID: 32732367
[TBL] [Abstract][Full Text] [Related]
11. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients.
Lorenz G; Moog P; Bachmann Q; La Rosée P; Schneider H; Schlegl M; Spinner C; Heemann U; Schmid RM; Algül H; Lahmer T; Huber W; Schmaderer C
Sci Rep; 2020 Oct; 10(1):18277. PubMed ID: 33106497
[TBL] [Abstract][Full Text] [Related]
12. Ruxolitinib in Alleviating the Cytokine Storm of Hemophagocytic Lymphohistiocytosis.
Jianguo L; Zhixuan Z; Rong L; Xiaodong S
Pediatrics; 2020 Aug; 146(2):. PubMed ID: 32680878
[TBL] [Abstract][Full Text] [Related]
13. Case report: Ruxolitinib as first-line therapy for secondary hemophagocytic lymphohistiocytosis in patients with AIDS.
Liu X; Zhu X; Zhou X; Xie Y; Xiang D; Wan Z; Huang Y; Zhu B
Front Immunol; 2022; 13():1012643. PubMed ID: 36263041
[TBL] [Abstract][Full Text] [Related]
14. Dengue Infection Complicated by Hemophagocytic Lymphohistiocytosis: Experiences From 180 Patients With Severe Dengue.
Kan FK; Tan CC; Von Bahr Greenwood T; Khalid KE; Supramaniam P; Hed Myrberg I; Tan LH; Henter JI
Clin Infect Dis; 2020 May; 70(11):2247-2255. PubMed ID: 31188423
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and Management of Adult Malignancy-Associated Hemophagocytic Lymphohistiocytosis.
Lee JC; Logan AC
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980725
[TBL] [Abstract][Full Text] [Related]
16. Ruxolitinib for secondary hemophagocytic lymphohistiocytosis: First case report.
Sin JH; Zangardi ML
Hematol Oncol Stem Cell Ther; 2019 Sep; 12(3):166-170. PubMed ID: 28834694
[TBL] [Abstract][Full Text] [Related]
17. Ruxolitinib in conjunction with the HLH-94 protocol for Epstein-Barr virus-related hemophagocytic lymphohistiocytosis in the intensive care unit: A case report.
Huang Z; Xie J
Medicine (Baltimore); 2021 Mar; 100(11):e25188. PubMed ID: 33726009
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of hemophagocytic lymphohistiocytosis in patients in the intensive care unit].
Eichenauer DA; La Rosée P
Inn Med (Heidelb); 2023 Oct; 64(10):955-960. PubMed ID: 37702780
[TBL] [Abstract][Full Text] [Related]
19. Case Report: Secondary Hemophagocytic Lymphohistiocytosis (sHLH) and
Gautam S; Sharma G; Singla S; Garg S
Front Med (Lausanne); 2022; 9():835421. PubMed ID: 35783658
[TBL] [Abstract][Full Text] [Related]
20. Hemoperfusion with CytoSorb to Manage Multiorgan Dysfunction in the Spectrum of Hemophagocytic Lymphohistiocytosis Syndrome in Critically Ill Children.
Bottari G; Murciano M; Merli P; Bracaglia C; Guzzo I; Stoppa F; Pardeo M; Nunziata J; Del Bufalo F; Genuini L; De Benedetti F; Locatelli F; Cecchetti C
Blood Purif; 2022; 51(5):417-424. PubMed ID: 34344006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
